Andrew Mok
Stock Analyst at Barclays
(2.66)
# 1,826
Out of 4,810 analysts
155
Total ratings
53.7%
Success rate
-2.43%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $270 → $322 | $286.78 | +12.28% | 8 | Apr 11, 2025 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $21 → $23 | $24.19 | -4.92% | 7 | Apr 10, 2025 | |
| ASTH Astrana Health | Initiates: Equal-Weight | $36 | $33.76 | +6.64% | 1 | Apr 1, 2025 | |
| RDNT RadNet | Maintains: Overweight | $74 → $60 | $53.08 | +13.04% | 7 | Mar 24, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Equal-Weight | $43 → $35 | $24.73 | +41.53% | 12 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Maintains: Underweight | $8 → $9 | $19.43 | -53.68% | 4 | Feb 28, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $271 → $249 | $175.50 | +41.88% | 21 | Feb 27, 2025 | |
| CYH Community Health Systems | Maintains: Equal-Weight | $5 → $4 | $2.49 | +60.64% | 5 | Feb 20, 2025 | |
| DVA DaVita | Maintains: Equal-Weight | $164 → $169 | $146.28 | +15.53% | 10 | Feb 18, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $161 | $120.91 | +33.16% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $71 → $73 | $68.92 | +5.92% | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $372 → $339 | $335.50 | +1.04% | 4 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $118 | $102.30 | +15.35% | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $339 | $328.63 | +3.16% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $392 → $366 | $335.55 | +9.07% | 9 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $501 → $512 | $437.77 | +16.96% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $655 → $642 | $583.59 | +10.01% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $93 | $62.28 | +49.33% | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $2 | $5.53 | -63.83% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $99.24 | -16.36% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $21.07 | +66.11% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.79 | +54.04% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $91.58 | +3.73% | 7 | Aug 2, 2022 |
Humana
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $270 → $322
Current: $286.78
Upside: +12.28%
Privia Health Group
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $21 → $23
Current: $24.19
Upside: -4.92%
Astrana Health
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $33.76
Upside: +6.64%
RadNet
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $53.08
Upside: +13.04%
Acadia Healthcare Company
Feb 28, 2025
Downgrades: Equal-Weight
Price Target: $43 → $35
Current: $24.73
Upside: +41.53%
Alignment Healthcare
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $19.43
Upside: -53.68%
Universal Health Services
Feb 27, 2025
Maintains: Overweight
Price Target: $271 → $249
Current: $175.50
Upside: +41.88%
Community Health Systems
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.49
Upside: +60.64%
DaVita
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $146.28
Upside: +15.53%
Tenet Healthcare
Feb 13, 2025
Maintains: Overweight
Price Target: $190 → $161
Current: $120.91
Upside: +33.16%
Feb 13, 2025
Maintains: Overweight
Price Target: $71 → $73
Current: $68.92
Upside: +5.92%
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $372 → $339
Current: $335.50
Upside: +1.04%
Feb 7, 2025
Maintains: Overweight
Price Target: $116 → $118
Current: $102.30
Upside: +15.35%
Jan 31, 2025
Maintains: Overweight
Price Target: $420 → $339
Current: $328.63
Upside: +3.16%
Jan 27, 2025
Maintains: Overweight
Price Target: $392 → $366
Current: $335.55
Upside: +9.07%
Jan 24, 2025
Maintains: Overweight
Price Target: $501 → $512
Current: $437.77
Upside: +16.96%
Jan 17, 2025
Maintains: Overweight
Price Target: $655 → $642
Current: $583.59
Upside: +10.01%
Dec 13, 2024
Maintains: Overweight
Price Target: $91 → $93
Current: $62.28
Upside: +49.33%
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $5.53
Upside: -63.83%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $99.24
Upside: -16.36%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $21.07
Upside: +66.11%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.79
Upside: +54.04%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $91.58
Upside: +3.73%